trusted seller
Trasturel Trastuzumab 440mg Injection

Trasturel Trastuzumab 440mg Injection

8600 INR/Piece

Product Details:

  • Pacakaging (Quantity Per Box) 1 vial of 440mg + 1 vial 20ml solvent.
  • Origin of Medicine Biotechnology/ Recombinant DNA technology.
  • Dosage Form Injection (after reconstitution).
  • Indication Indicated for HER2-positive breast cancer (early and metastatic), and HER2-positive metastatic gastric cancer.
  • Salt Composition Trastuzumab 440mg.
  • Drug Type Anticancer (Monoclonal Antibody).
  • Ingredients Trastuzumab (lyophilized powder) with accompanying solvent for reconstitution.
  • Click to View more
X

Trasturel Trastuzumab 440mg Injection Price And Quantity

  • 8600 INR/Piece
  • 1 Piece
  • Reconstitute with provided solvent under aseptic conditions before use.
  • Single use vial. Discard any unused reconstituted solution.
  • Fever, chills, nausea, cardiac dysfunction, infusion-related reactions, increased risk of infection.
  • Monitor cardiac function before and during therapy.
  • White to pale yellow lyophilized powder.
  • Trasturel
  • Intravenous infusion only.
  • History of hypersensitivity to trastuzumab or any excipients.
  • 24 months when stored as recommended.
  • Oncology/Antineoplastic agent.
  • Yes, to be used under medical supervision only.

Trasturel Trastuzumab 440mg Injection Product Specifications

  • Indicated for HER2-positive breast cancer (early and metastatic), and HER2-positive metastatic gastric cancer.
  • Trastuzumab 440mg.
  • Store at 2C to 8C. Do not freeze. Protect from light.
  • Injection (after reconstitution).
  • Lyophilized powder for injection.
  • Biotechnology/ Recombinant DNA technology.
  • Adults only. Not recommended for pediatric use.
  • Patients with HER2-positive breast cancer, and HER2-positive metastatic gastric cancer.
  • Administered as an intravenous infusion after reconstitution and dilution. Follow prescribing information for detailed dosing and administration.
  • Anticancer (Monoclonal Antibody).
  • Trastuzumab (lyophilized powder) with accompanying solvent for reconstitution.
  • 440mg per vial. Dosage to be determined by physician based on condition and patient weight.
  • 1 Vial + 1 Solvent (20 ml) per box.
  • 1 vial of 440mg + 1 vial 20ml solvent.
  • Monoclonal antibody; targets HER2 receptors for the treatment of specific cancers.
  • Reconstitute with provided solvent under aseptic conditions before use.
  • Single use vial. Discard any unused reconstituted solution.
  • Fever, chills, nausea, cardiac dysfunction, infusion-related reactions, increased risk of infection.
  • Monitor cardiac function before and during therapy.
  • White to pale yellow lyophilized powder.
  • Trasturel
  • Intravenous infusion only.
  • History of hypersensitivity to trastuzumab or any excipients.
  • 24 months when stored as recommended.
  • Oncology/Antineoplastic agent.
  • Yes, to be used under medical supervision only.

Product Description

Product introduction

Trasturel 150mg Injection is used in the treatment of breast and stomach cancer. It works by killing the cancer cells by inhibiting HER2 (human epidermal growth factor receptor protein).

Trasturel 150mg Injection is given as an injection by a qualified medical professional. Your doctor will decide what dose is necessary and how often you need to take it. This will depend on what you are being treated for and may change from time to time. You should take it exactly as your doctor has advised. Taking it in the wrong way or taking too much can cause very serious side effects. It may take several weeks or months for you to see or feel the benefits but do not stop taking it unless your doctor tells you to.

The most common side effects of this medicine include nausea, headache, rash, insomnia, and infection. This medicine may reduce the number of blood cells (decrease red blood and white blood cells) in your blood, thereby, increasing the susceptibility to infections. Regular blood tests are required to check your blood cells along with heart, liver, and blood uric acid levels. You must have to inform your doctor if you experience breathlessness, cough, shivering, swelling of legs and arm.



Advanced Targeted Cancer Therapy

Trasturel functions as a monoclonal antibody designed through recombinant DNA technology to specifically target HER2 receptors. This targeted action helps to inhibit the proliferation of cancer cells in HER2-positive breast and metastatic gastric cancer, offering a tailored approach in oncology treatment.


Precise Dosage and Administration

Dosage of Trasturel Trastuzumab 440mg Injection is determined by a physician based on patient body weight and clinical condition. The powder must be carefully reconstituted with the provided solvent under aseptic conditions and then diluted before intravenous administration. Only use as a single dose; any remaining solution should be discarded.


Safety and Monitoring Advice

Patients receiving Trasturel should have their cardiac function monitored before and during therapy, as cardiac dysfunction can occur. Common side effects include fever, chills, nausea, and infusion-related reactions. Use in adults only and avoid in patients with known hypersensitivity to trastuzumab or its excipients.

FAQ's of Trasturel Trastuzumab 440mg Injection:


Q: How is Trasturel Trastuzumab 440mg Injection administered?

A: Trasturel is administered exclusively by intravenous infusion, following reconstitution with the supplied solvent under aseptic conditions. Only qualified healthcare professionals should prepare and administer the injection.

Q: What are the main indications for Trasturel Trastuzumab?

A: Trasturel is indicated for the treatment of adults with HER2-positive breast cancer (early and metastatic) as well as HER2-positive metastatic gastric cancer.

Q: When should cardiac function be monitored during Trasturel therapy?

A: Cardiac function should be evaluated before starting treatment and periodically during therapy, as Trasturel can cause cardiac dysfunction in some patients.

Q: Where should Trasturel be stored to maintain its effectiveness?

A: Store Trasturel at 2C to 8C, protected from light. Do not freeze the product. Always follow labeled storage instructions to ensure stability and efficacy.

Q: What is the process for preparing Trasturel before administration?

A: Prior to infusion, Trasturel must be reconstituted with the provided 20ml solvent using aseptic techniques, then further diluted according to prescribing information before intravenous administration.

Q: Is Trasturel suitable for pediatric patients?

A: No, Trasturel is intended for use in adults only and is not recommended for pediatric patients.

Q: What benefits does Trasturel offer for patients with HER2-positive cancers?

A: By specifically targeting HER2 receptors, Trasturel disrupts cancer cell growth, thereby offering a targeted, effective option for patients with HER2-positive breast and gastric cancers.

Tell us about your requirement
product

Price:

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
Mobile number

Email

Other Products in 'Anti Cancer Medicines' category



Back to top